SEC Form D · Amendment · filed March 7, 2023
Transition Bio, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Gregory L. Miller · CAMBRIDGE, MAExec · DirectorTuomas L. Knowles · CAMBRIDGE, MAExecAl K. Sandrock · CAMBRIDGE, MADirectorGeorge K. Martin · CAMBRIDGE, MADirectorSamuel K. Cohen · CAMBRIDGE, MADirectorMartin L. Kulander · CAMBRIDGE, MAExecKathy K. Yi · CAMBRIDGE, MADirectorConnor K. Mcdermott · CAMBRIDGE, MADirectorAnthony Salewski · San Francisco, CAExec · DirectorMichael Durbin · San Francisco, CAExecGary Michel · San Francisco, CADirectorLori Hardwick · San Francisco, CADirectorBen Brigeman · San Francisco, CAExecSiddharth Ramakrishnan · San Francisco, CADirectorShawn O'Neil · Aliso Viejo, CADirectorTibor Juhasz · Aliso Viejo, CAExecWilliam Link · Aliso Viejo, CAExec · DirectorTom Frinzi · Aliso Viejo, CADirectorRebecca A. Bell · Macon, GAExecManeklal G. Patel · Macon, GADirectorKathy K. Yi · CAMBRIDGE, MADirectorConnor K. Mcdermott · CAMBRIDGE, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗